Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-27 Purchase | 2026-07-29 7:09 pm | Scribe Therapeutics Inc. | SCTX | AH Bio Fund II L.P. AH Equity Partners Bio II L.L.C. AH Bio Fund III L.P. AH Equity Partners Bio III L.L.C. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner | 333,333 | $15 | $4,999,995 | 2,385,075 (Indirect) | View |
| 2026-07-27 Purchase | 2026-07-29 6:50 pm | Scribe Therapeutics Inc. | SCTX | GORDON CARL L Director | 1,000,000 | $15 | $15,000,000 | 1,348,825 (Indirect) | View |
| 2026-07-27 Purchase | 2026-07-29 6:47 pm | Scribe Therapeutics Inc. | SCTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 1,000,000 | $15 | $15,000,000 | 1,348,825 (Indirect) | View |
| 2026-07-24 Purchase | 2026-07-28 9:30 pm | Scribe Therapeutics Inc. | SCTX | Aghazadeh Behzad Avoro Capital Advisors LLC Avoro Ventures LLC See Remarks 10% Owner | 2,391,238 | $15.16 | $36,259,761 | 3,088,888 (Indirect) | View |
| 2026-07-23 Purchase | 2026-07-27 9:42 pm | Scribe Therapeutics Inc. | SCTX | Lucas Svetlana Chief Business Officer | 3,000 | $15 | $45,000 | 231,399 (Indirect Direct) | View |
| 2026-07-23 Purchase | 2026-07-27 9:20 pm | Scribe Therapeutics Inc. | SCTX | Parrot David Chief Financial Officer | 2,666 | $15 | $39,990 | 229,094 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-27 Conversion | 2026-07-29 7:09 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | AH Bio Fund II L.P. AH Equity Partners Bio II L.L.C. AH Bio Fund III L.P. AH Equity Partners Bio III L.L.C. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner | 19,030,739 | $0 | 2,385,075 (Indirect) | View |
| 2026-07-27 Conversion | 2026-07-29 6:50 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | GORDON CARL L Director | 2,414,497 | $0 | 1,348,825 (Indirect) | View |
| 2026-07-27 Conversion | 2026-07-29 6:47 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 2,414,497 | $0 | 1,348,825 (Indirect) | View |
| 2026-07-27 Conversion | 2026-07-29 4:21 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | Doudna Jennifer A 10% Owner | 86,599 | $0 | 603,547 (Direct) | View |
| 2026-03-13 Option Award | 2026-07-28 4:46 pm | N/A 2036-03-12 | Scribe Therapeutics Inc. | SCTX | Staahl Brett 10% Owner | 43,525 | $0 | 43,525 (Direct) | View |
| 2026-03-13 Option Award | 2026-07-27 9:42 pm | N/A 2036-03-12 | Scribe Therapeutics Inc. | SCTX | Lucas Svetlana Chief Business Officer | 228,399 | $0 | 231,399 (Direct) | View |
| 2026-03-13 Option Award | 2026-07-27 9:26 pm | N/A 2036-03-12 | Scribe Therapeutics Inc. | SCTX | Oakes Benjamin L. President, CEO | 707,352 | $0 | 707,352 (Direct) | View |
| 2026-07-23 Option Award | 2026-07-27 9:25 pm | N/A 2036-07-22 | Scribe Therapeutics Inc. | SCTX | GORDON CARL L Director | 14,725 | $0 | 14,725 (Direct) | View |
| 2026-07-23 Option Award | 2026-07-27 9:23 pm | N/A 2036-07-22 | Scribe Therapeutics Inc. | SCTX | Watson James Dean Director | 14,725 | $0 | 14,725 (Direct) | View |
| 2026-07-23 Option Award | 2026-07-27 9:22 pm | N/A 2036-07-22 | Scribe Therapeutics Inc. | SCTX | Bleharski Joshua Director | 14,725 | $0 | 14,725 (Direct) | View |
| 2026-03-13 Option Award | 2026-07-27 9:20 pm | N/A 2036-03-12 | Scribe Therapeutics Inc. | SCTX | Parrot David Chief Financial Officer | 227,761 | $0 | 229,094 (Direct) | View |
| 2026-07-23 Option Award | 2026-07-27 9:04 pm | N/A 2036-07-22 | Scribe Therapeutics Inc. | SCTX | Aghazadeh Behzad Avoro Capital Advisors LLC Avoro Ventures LLC See Remarks | 14,725 | $0 | 14,725 (Direct) | View |
Ownership | 2026-07-23 9:45 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | ELI LILLY & Co 10% Owner | 0 | $0 | 1,054,828 (Direct) | View |
Ownership | 2026-07-23 9:32 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 0 | $0 | 348,825 (Indirect) | View |
Ownership | 2026-07-23 9:32 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | AH Bio Fund II L.P. AH Equity Partners Bio II L.L.C. AH Bio Fund III L.P. AH Equity Partners Bio III L.L.C. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner | 0 | $0 | 2,749,392 (Indirect) | View |
Ownership | 2026-07-23 9:28 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | Staahl Brett 10% Owner | 0 | $0 | 551,039 (Direct) | View |
Ownership | 2026-07-23 9:27 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | Doudna Jennifer A 10% Owner | 0 | $0 | 603,547 (Direct) | View |
Ownership | 2026-07-23 9:26 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | GORDON CARL L Director | 0 | $0 | 348,825 (Indirect) | View |
Ownership | 2026-07-23 9:22 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | Lucas Svetlana Chief Business Officer | 0 | $0 | 122,027 (Direct) | View |
Ownership | 2026-07-23 9:20 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | Oakes Benjamin L. President, CEO | 0 | $0 | 681,683 (Direct) | View |
Ownership | 2026-07-23 9:18 pm | N/A 2031-12-15 | Scribe Therapeutics Inc. | SCTX | Parrot David Chief Financial Officer | 0 | $0 | 122,542 (Direct) | View |
Ownership | 2026-07-23 9:00 pm | N/A N/A | Scribe Therapeutics Inc. | SCTX | Aghazadeh Behzad Avoro Capital Advisors LLC Avoro Ventures LLC See Remarks | 0 | $0 | 697,650 (Indirect) | View |